Briefing Book Article, 47th Parliament

Science and research

Go to section

Key issue

Australia has a well-performing research sector but has consistently been less successful translating research outcomes into commercially successful products and services.

In relation to spending on research and development, Australia is well behind international leaders and middle ranked among developed nations. Many stakeholders, particularly in the university sector, believe that the research funding system needs reform, both in terms of the quantity of funding and how it is invested.

Introduction

Parliament is often required to consider issues involving complex scientific concepts and where future impacts are uncertain. Similarly, the Australian Government relies on access to a strong evidence base for the development of policies to protect health and wellbeing and foster economic growth. It is therefore imperative that parliamentarians and government have access to expert advice on a wide range of issues.

The COVID-19 pandemic, and the rapid development of vaccines, have highlighted the critical role of science in protecting social wellbeing. Ensuring that policy frameworks encourage the research and development (R&D) that can address challenges, such as the pandemic, helps underpin the long-term resilience of Australian society. Additionally, Australia’s prosperity will increasingly be linked to its ability to commercialise R&D into new innovations and industries.

The development of successful new products and services is the last step in a process of knowledge generation and transfer that can take decades. The funding of this R&D and commercialisation process by governments and industry in Australia is well behind international leaders.

Despite research commercialisation being a focus of Australian Government policy for decades, Australia continues to perform relatively poorly in this area. Additionally, there are emerging concerns that the long-term focus on commercialisation may be coming at the expense of the basic research that forms the foundations of the innovation ‘pipeline’.

Scientific advice to Parliament

The provision of advice from the science sector to parliamentarians can occur through a variety of mechanisms, including via direct engagement with researchers, and through Science Meets Parliament and the Australian Council of Learned Academies (ACOLA, which includes the Australian Academy of Science and the Australian Academy of Technology and Engineering). The Parliamentary Library Research Branch also provides customised information, analysis and advice on any subject of interest to parliamentarians and their staff and to support parliamentary committees.

Parliamentary committees due to their smaller size and more informal procedures (relative to the 2 chambers) are ‘well suited to the gathering of evidence from expert groups or individuals’ (p. 641). Committees undertake inquiries on matters of policy and public interest and seek input from stakeholders to inform their deliberations. This input regularly includes evidence from the academic community and other experts provided through written submissions and oral presentations at public hearings.

Advice and policy support for Government

The new Minister for Industry and Science, Ed Husic, will be the 11th minister to hold the science portfolio in the last decade. In the new Government, science policy will sit within the Department of Industry, Science and Resources (p. 28). In addition to the department, there are several major sources of science policy advice to government, as outlined below.

CSIRO

The Commonwealth Scientific and Industrial Research Organisation is Australia’s public sector applied research organisation. CSIRO is a statutory authority constituted under the Science and Industry Research Act 1949 (SIR Act). CSIRO describes its purpose as ‘solving the greatest challenges through innovative science and technology’ and its functions under the SRI Act include undertaking research to support Australian industry and the Australian community. An example of these functions are the roadmaps that CSIRO regularly publishes, which investigate opportunities for Australian industry to take advantage of new and emerging technologies. In 2021–22, the Australian Government provided $949 million in funding to CSIRO (p. 253).

The Chief Scientist

Australia’s Chief Scientist provides independent advice on science, technology, and innovation to the Prime Minister and other ministers. The Chief Scientist’s role also includes advocating for Australian science internationally and championing the importance of scientific evidence to the Australian public. The Chief Scientist holds the position of Executive Officer to the National Science and Technology Council, which is chaired by the Prime Minister and is the ‘preeminent forum for providing scientific and technological advice for government policy and priorities’.

Dr Cathy Foley is Australia’s ninth Chief Scientist. She commenced in the role in January 2021 (replacing Dr Alan Finkel). At the commencement of her tenure as Chief Scientist, Dr Foley identified the 4 foundational issues she hoped to work on: digital capability; science, technology, engineering and mathematics (STEM) education; diversity in the research community; and open access to research (p. 6).

Industry Innovation and Science Australia

Innovation and Science Australia (ISA) was established in 2015 as part of the National Innovation and Science Agenda (NISA). ISA is an independent statutory board of entrepreneurs, investors, researchers and educators tasked with providing advice to Government as well as coordinating innovation policy across multiple portfolios. ISA has published many reports on innovation policy.

In 2021, ISA’s name was changed to Industry Innovation and Science Australia (IISA) to emphasise the Government’s efforts to increase the links between science and industry.

Evolving science and innovation policy frameworks

Since the 1980s, Australian innovation policy has gone through several distinct phases. Policy settings have ranged from more ‘interventionist’ approaches that attempted to build collaboration within an innovation system (including between government and industry) and more ‘free market’ approaches that aimed to use incentives to increase the pace, rather than change the direction, of innovation (pp. 182–184).

Some major science and innovation programs and reports within the last decade include:

Should science advice to Parliament be expanded?

There have been suggestions that additional mechanisms are required to increase the provision of independent science advice to Parliament and all parliamentarians. For example, a 2021 Senate Committee recommended a ‘Parliamentary Office of Science’ be established and modelled on the UK’s Parliamentary Office of Science and Technology (POST). The Australian Academy of Science is continuing to stimulate this debate, and highlighted the Parliamentary Budget Office as a successful example of another body providing advice to Parliament.

The Australian Labor Party’s (ALP) 2021 National Platform states that the ALP will establish a Parliamentary Office of Science to ‘provide independent, impartial scientific advice, evidence and data to the Parliament, and all Members and Senators’ (p. 68). The Australian Greens are also committed to the establishment of an independent POST. 

Spending on science, research, and innovation

The Global innovation index (GII) is an annual report providing statistical benchmarking of national innovation systems. The 2021 edition of the GII ranked Australia 25th of the 132 countries assessed (p. 47) and 24th of the 51 high-income countries.

As in previous years, Australia ranks well (15th) on innovation inputs including education and research, but less well (33rd) on innovation outputs, suggesting a weakness in translating research into commercial outcomes. Further analysis of the performance of Australia’s innovation system relative to other countries can be found in the Australian Innovation System Monitor.

In 2019–20, Australian gross expenditure on research and development (GERD), which includes research spending by business, government, higher education and the non-profit sector, was $35.6 billion. This amounts to 1.79% of GDP, placing Australia 20th among 132 countries for this metric (p. 47). GERD as a proportion of GDP has been falling since 2008 (p. 40). In 2019, business expenditure on research and development (BERD) in Australia was 0.92% of GDP, which is approximately half the OECD average (1.81%; p. 33). The ALP has committed to increasing investment in research and innovation to levels closer to 3% of GDP (p. 7)

Figure 1 shows spending on R&D since 2011–12 converted to 2021 prices. Although total spending remained relatively steady (in 2021 prices), business and government spending dropped, and higher education spending rose over this period.

Figure 1          Gross expenditure on research and development (GERD) by sector (in 2021 prices)
figure 1 graph showing Gross expenditure on research and development (GERD) by sector (in 2021 prices)

(a) Higher education estimates modelled in 2011–12.
(b) From 2013–14 Government, Private non-profit and Higher education estimates have been modelled.
(c) Where figures have been rounded, discrepancies may occur between the sum of the component items and totals.

Source: Australian Bureau of Statistics (ABS), Research and Experimental Development, Businesses, Australia, 2019–20 Financial Year, (Canberra: ABS, 2021). All figures have been converted to June 2021 prices using Parliamentary Library calculations.

The declining level of business expenditure on research is largely due to changes in Australia’s industry mix, including a decline in manufacturing and a transition in the mining sector from exploration and development to operations (p. 37).

Aggregate figures for Australian Government spending are also provided in the annual Science, Research and Innovation Budget Tables. In 2021–22, the estimated total government spending on science, research and innovation was $11.8 billion (note that this includes support for business and higher education, which in Figure 1 is allocated to each of those sectors).

Australian Government investment in 2021–22 comprised:

  • Australian Government research activities: $2.3 billion, including CSIRO, Defence Science and Technology Group, and other government R&D
  • business enterprise sector: $2.9 billion, almost all of which is spent on the R&D Tax Incentive, which provides a tax offset for businesses to undertake R&D activities
  • higher education sector: $3.7 billion, including the research block grants, Australian Research Council grants, and NHMRC grants to universities
  • multisector: $2.8 billion, including NHMRC’s non-university spending, Cooperative Research Centres, Rural R&D Corporations, other health R&D, and energy and environment R&D.

University research funding

Australian universities receive funding to undertake research from a variety of sources. The largest source of funding (56%) is from general university funds. Other key sources of funding include:

  • research block grants, which provide funding for research and research training ($2 billion in funding in 2022)
  • various competitive grants programs including: the Australian Research Council administered National Competitive Grants Program (which includes the Discovery Program for foundational research and the Linkage Program for research undertaken in partnership with industry); NHMRC grants; and Medical Research Future Fund grants
  • student fees and government support for research infrastructure.

A more detailed discussion on university research funding can be found in the Parliamentary Library’s quick guide on the subject.

Research commercialisation agenda

The Australian university sector is generally highly ranked in international comparisons of research performance. In 2022, there are 7 Australian universities in the Top 100 of the QS World University Rankings and 6 in the Top 100 of the Times Higher Education rankings.

Australian researchers also perform well in measurements of academic publications, producing 4.1% of academic publications globally in 2020, more than 10 times Australia’s share of the global population (0.3%). Australian authors perform well when comparing citations of research publications. Australian researchers also perform above the OECD average in terms of scientific publications generated per dollar invested in research.

Despite these successes, Australian research does not appear to be as effective at being translated into successful commercial products. This is a long-standing problem that has been the focus of the efforts of successive governments to expand the innovative capacity of the Australian economy.  It has long been thought that insufficient knowledge transfer, in part due to a lack of collaboration between industry and Australian public sector researchers, contributes to the low levels of commercialisation.

Australia ranks last in the OECD (by a significant margin) in relation to the percentage of businesses that develop innovations in collaboration with public sector research organisations. As shown in the Australian Innovation System Monitor, this result ‘reflects unfavourably on the ability of Australian businesses and research institutions to maximise the return on public investment in science and research’.

The 2016 Review of the R&D Tax Incentive recommended a collaboration premium be added to the R&D Tax Incentive to provide a financial incentive to businesses to collaborate with public sector research organisations (p. 3). This recommendation was reiterated in ISA’s Australia 2030 report (p. 104). To date, the Australian Government has not implemented this recommendation.

In 2021, the Morrison Government announced the University Research Commercialisation Action Plan (Commercialisation Action Plan), a $2.2 billion investment to drive commercialisation and increase collaboration between industry and universities. Key components of the plan include:

  • $1.6 billion for Australia’s Economic Accelerator, which will provide grant funding to universities with projects at proof-of-concept or proof-of-scale projects that have high commercialisation potential and are aligned to one of the National Manufacturing Priorities
  • $296 million for the National Industry PhD Program to support 1,800 students to undertake industry-focused PhDs
  • $243 million for the Trailblazer Universities Program, a competitive grant program that will select universities to partner with industry to work on research aligned with the National Manufacturing Priorities.

The announcement of Australia’s Economic Accelerator was largely supported by stakeholders within the science and research field. The Morrison Government introduced 2 Bills to legislate Australia’s Economic Accelerator and the Trailblazer Universities Program, which lapsed at the dissolution of the 46th Parliament.

Prior to the election, the ALP indicated it would support legislating Australia’s Economic Accelerator and stated in its National Reconstruction Fund policy that it would invest in supporting Australian companies to commercialise new renewable energy and low emissions technologies. The ALP earlier announced it would introduce a Startup Year program which would offer loans to 2,000 final-year students and recent graduates to support their participation in commercialisation accelerator programs.

Labor has also committed to creating an Advanced Strategic Research Agency (ASRA) in the Defence portfolio, emphasising that ‘ASRA would be modelled after the United States Government’s ground-breaking Defence Advanced Research Projects Agency (DARPA)’. For further information, see the article on ‘The Australian Government public sector’ elsewhere in this Briefing book, and a Parliamentary Library FlagPost about the ‘DARPA model’.

Commercialisation concerns

There are concerns among some university stakeholders that the focus on research translation could come at the expense of support for foundational or basic research that is not suitable for commercialisation.

The Vice-Chancellor of the Australian National University, Professor Brian Schmidt, highlighted that applied research builds on existing basic research and argued that the new Government should ensure that the right balance is struck between basic and applied research.

The President of the Australian Academy of Science, Professor John Shine, highlighted the role of fundamental science in gradually building the understanding of RNA technologies necessary for the rapid development of COVID-19 vaccines. Professor Shine stated that government funding for research should act as ‘patient capital’ and quick or easy returns should not be expected.

Researchers in the humanities and social sciences have also noted that the Commercialisation Action Plan’s focus on the National Manufacturing Priorities means that it will be almost impossible for researchers in these fields to attract funding under the plan.

Calls for reforms to research funding

Many university stakeholders are calling for reforms to how research is funded in Australia. These range from a focus on specific issues, such as removing the ability of ministers to intervene in the approval of Australian Research Council grants, to calls for broad systemic reform.

The Australian Academy of Science stated that Australia’s approach to funding science is ‘not fit for purpose’ and recommended a whole-of-government review to ‘identify the optimal operation, funding arrangements and architecture of the Australian science and research system’.

Similarly, the Vice-Chancellor of the University of Melbourne, Professor Duncan Maskell, stated there is a need to ‘tear up our research funding model and … start from scratch’. Professor Maskell suggested that the Government should fund a higher proportion of research so that it does not need to be subsidised by international student fees. Professor Schmidt stated that the Albanese Government had a ‘clean slate’ to fix ‘long-standing problems with the research ecosystem in Australia’. 

Further reading

Industry Innovation and Science Australia (IISA), Driving Effective Government Investment in Innovation, Science and Research, (Canberra: IISA, January 2021).

Tim Brennan, Hazel Ferguson and Ian Zhou, ‘Science and research’, Budget Review 2022–23, Research paper, 2021-22, (Canberra: Parliamentary Library, April 2022), 80–84.

Hazel Ferguson, University Research Funding: a Quick Guide, Research paper series, 2021–22, (Canberra: Parliamentary Library, February 2022).

Tim Brennan and Hazel Ferguson, ‘Independence of the Australian Research Council’, FlagPost (blog), Parliamentary Library, 3 June 2022.